In addition, systemic levels of complement C3 and C4 have been shown to be higher in patients with metabolic syndrome [54], and C1q expression has been reported to be dysregulated in adipocytes during insulin resistance [35], which also occurs in cachexia [55]. Here, C3 is linked to metabolic syndrome.